Table 2. The impact of Haemophilus influenzae type b vaccine on discounted disease burden and program costs.

	Hib vaccine	No Hib vaccine	Incremental value
Health outcome
Case	8,756	10,334	1,579
Death	1,022	1,395	373
DALY	20,535	28,551	8,016
Costs (US$)
Vaccine delivery cost
Vaccine costs	14,069,633.04	2,665,366
Program implementation cost	3,107,207.00	2,851,423
Subtotal	17,176,840.04	5,516,789	11,660,051
Disease treatment cost
Societal perspective	2,496,575	4,285,342	1,788,767
Governmental perspective	1,459,322	2,139,691	680,368
Total cost
Societal perspective	19,673,415	9,802,131	9,871,284
Governmental perspective	18,636,162	7,656,480	10,979,682

Note: Hib, Haemophilus influenzae type b; DALY, disability-adjusted life year.